Heinrich Wieland Prize: Closing in on the cause of diabetes
- Details
- Category: Research
For his milestone discoveries on the development of diabetes, Prof. Markus Stoffel from the Institute of Molecular Systems Biology at the ETH Zurich was awarded the Heinrich Wieland Prize, one of the most treasured science awards in Germany. He received the distinction with EUR 50,000 prize money for his work in deciphering important mechanisms of blood sugar regulation and lipid metabolism in the body.
InforSense Collaborates with Industry Innovators to Enable Virtual Drug Discovery
- Details
- Category: Research
InforSense Ltd., the leading provider of next generation business and scientific intelligence tools, has successfully completed a pilot project at world leading pharmaceutical company GlaxoSmithKline (GSK) to enable virtual drug discovery through virtual outsourcing of data analysis via secure Grid technology.
Research agreement for the development of insulin-producing cells from human stem cells
- Details
- Category: Research
Novo Nordisk A/S, a world leader in diabetes care, Cellartis AB, a forefront stem cell biotechnology company, and Lund University Stem Cell Center today signed a collaborative research agreement for the development of insulin-producing cells from human stem cells.
A new journal where molecular biology meets clinical research
- Details
- Category: Research
The European Molecular Biology Organization (EMBO) has announced the introduction of EMBO Molecular Medicine, a new journal dedicated to a research discipline focused on the interface between molecular biology and clinical research. The new journal, launching in 2009, will publish original research offering molecular insights into cellular and systemic processes underlying defined human diseases as well as potential clinical applications for diagnosis, prevention and therapy.
EMEA half-year report for 2008 shows activities to be on target
- Details
- Category: Research
At its 60th meeting, held in London on 2 October 2008, the Management Board of the European Medicines Agency (EMEA) welcomed the half-year report for 2008 presented to them by EMEA Executive Director Thomas Lönngren.
New Media Offers Cost-Efficient Ways to Reach and Engage Targets
- Details
- Category: Research
Over 145 million U.S. adults use the Internet to research health information, according to pharmaceutical and healthcare market research company Manhattan Research. The company has just released Cybercitizen Health v8.0, a multi-client study and strategic advisory service focused on how consumers use media and technology for health information and its impact on treatment and product decisions.
Medicines regulators on both sides of the Atlantic confirm commitment to cooperation on medicines
- Details
- Category: Research
The European Commission (EC), the European Medicines Agency (EMEA) and the United States Food and Drug Administration (FDA) have affirmed their commitment to regulatory cooperation and to intensifying their interactions in several new areas.
More Pharma News ...
- Philips develops ultrasound-activated microbubbles for localized delivery of cancer drugs
- Pharmaceutical Forum Concluded Successfully
- FDA Analysis on Cholesterol Lowering Medications
- Life Competence - the first global picture on the EU-funded health research
- European Consumers' Tools to Retrieve Health Information Online
- A New Computer-Modelling Tool to Improve Psoriasis Management and Treatment Outcomes
- Genzyme Marks Grand Opening of New Science Center